MedPath

The exploratory study to determine predictive biomarkers of response to immune checkpoint inhibitors for patients with metastatic urological cancers

Not Applicable
Conditions
urological cancers
Registration Number
JPRN-UMIN000038617
Lead Sponsor
Department of Urology, Graduate School of Medicine, Yamaguchi University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
190
Inclusion Criteria

Not provided

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath